InvestorsHub Logo
Followers 563
Posts 39671
Boards Moderated 2
Alias Born 06/08/2006

Re: EL CHAPO post# 101

Monday, 12/17/2018 8:33:48 AM

Monday, December 17, 2018 8:33:48 AM

Post# of 346
$INNT Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019

Let’s see if she crosses that $4 mark today.